Key result
TAVI linked to up to ~19-point KCCQ gains across all frailty groups.
Why the study?
It was unclear whether preoperative frailty status influences health-related quality of life and patients' self-rated health after TAVI.
Does preoperative frailty level influence the improvement in health-related quality of life 1 year after TAVI in patients >65 years?
Does preoperative frailty level influence the improvement in health-related quality of life 1 year after TAVI in patients >65 years?
TAVI significantly improves health-related quality of life and self-rated health at 1 year, and the magnitude of this benefit is independent of baseline mild-to-moderate frailty.
TAVI may confer consistent HRQoL gains across mild frailty; supports consensus but leaves causal effects open in observational data.
Introduction It is unclear if preoperative frailty status influences health-related quality of life (HRQoL) and patients’ self-rated health after transcatheter aortic valve implantation (TAVI). Therefore, we compared changes in HRQoL and self-rated health from before to 1-year after TAVI in relation to preoperative frailty level. Methods Patients >65 years accepted for TAVI at a Swedish University Hospital, were eligible for inclusion. Twelve patients (4.8%) died before the 1-year follow-up. To estimate preoperative frailty, we used Clinical Frailty Scale (CFS), divided in three frailty groups. Kansas City Cardiomyopathy Questionnaire (KCCQ) and the EQ-VAS in EQ5D (scale 1–100) were used to evaluate patients’ HRQoL and self-rated health, pre-and postoperatively. Paired T-tests were used to compare KCCQ and EQ-VAS within frailty groups. One-way ANOVA-test was used to compare changes between groups. Results In total, 209 TAVI patients (mean age 81.7 years, (SD 4.8), 44.5% women) with measurements both before and 1-year after TAVI were included in a prospective observational study. Preoperatively, 49/209 (23%) of the patients were assessed as not frail (CFS 2-3), 123/209 (59%) as very mild frail (CFS 4) and 37/209 (18%) as mild frail (CFS 5). One year after TAVI, HRQoL improved significant in all three frailty groups. The mean differences in KCCQ in CFS 2-3 group were 11.5 (95% confidence interval (CI): 7.1–15.9), CFS 4: 17.9 (95% CI: 14.3–21.5), CFS 5; 19.3 (95% CI: 10.8–27.8). The changes did not differ significantly between the groups (p=0.12). The mean differences in EQ-VAS in CFS 2-3 were 11.2 (95% CI: 6.5–16.0); CFS 4: 12.0 (95% CI: 8.4–15.6); CFS 5: 13.9 (95 % CI: 6.1–21.8), without significant intergroup differences (p=0.82). Conclusions TAVI improved patients’ HRQoL and self-rated health. The magnitude of improvement was independent of preoperative frailty level.
No takes yet. Share an insight, caveat, or question.
Lachonius et al. (2025) studied this question. TAVI improved HRQoL and self-rated health significantly across all frailty groups with KCCQ increments of 11.5 to 19.3 and EQ-VAS increases of 11.2 to 13.9 points.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: